Diabetes technology

Impact of transitioning from conventional blood glucose monitoring to continuous glucose monitoring on glycemic control and self-management in adults with type 2 diabetes on oral glucose-lowering medications

Diabetes Res Clin PractPublished Prospective single-arm study

Authors' conclusion

Switching from conventional SMBG to CGM significantly improved glycemic control and self-management in PwT2D treated with oral ADMs. This observation highlights the potential for broader integration of CGM into this population.

Study context

Population
Adults with T2D managed with oral glucose-lowering medications
Participants
108 adults
Exposure
Transition from conventional self-monitoring of blood glucose (SMBG) to continuous glucose monitoring (CGM), before vs after
  • CGMn = 108
Outcome
Glycemic control and self-management
Follow-up
12 weeks

Main finding

As reported in the abstract

HbA1c, baseline to 12 weeks
7.93 % to 7.31 % (p < 0.001)
Mean capillary glucose, baseline to 12 weeks
191 mg/dL to 180 mg/dL (p < 0.001)
Time in range
70 % (SD = 6.86)
IGMSS Capability score
16.1 to 30.3 (p < 0.001)
IGMSS Opportunity score
19.8 to 35 (p < 0.001)
IGMSS Motivation score
12.3 to 23.3 (p < 0.001)
IGMSS scale score
42 to 75.6 (p < 0.001)

Observational data: associations, not effects.

Further findings

Factors associated with endpoint IGMSS scores · 12 weeks

Longer diabetes duration associated with lower endpoint IGMSS scores
P = 0.024
More frequent SMBG associated with lower endpoint IGMSS scores
P = 0.012
Co-morbidities linked to higher endpoint IGMSS scores
P = 0.03

Original publication

Impact of transitioning from conventional blood glucose monitoring to continuous glucose monitoring on glycemic control and self-management in adults with type 2 diabetes on oral glucose-lowering medications. Diabetes Res Clin Pract. Published 5 September 2025. doi:10.1016/j.diabres.2025.112458

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.